Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Osisko Metals Incorporated | 0B51 | Apr 17, 2025 | 0.25 | -6.11 |
OSMOSUN S.A. EO 1 | V05 | Apr 17, 2025 | 1.15 | 0.00 |
OssDsign | 5J6 | Apr 17, 2025 | 1.24 | +4.20 |
Ostrom Climate Solutions Inc | 9EAA | Apr 17, 2025 | 0.01 | -8.70 |
OTE (CR) | OTE | Apr 17, 2025 | 15.59 | +0.78 |
Otello Corporation | OS3 | Apr 17, 2025 | 0.74 | -0.81 |
Otis Worldwide Corporation | 4PG | Apr 17, 2025 | 85.88 | -1.81 |
Otovo ASA | 89K | Apr 17, 2025 | 0.10 | +10.05 |
OTP Bank | OTP | Apr 17, 2025 | 59.06 | -2.35 |
OTRS AG | TR9 | Apr 17, 2025 | 16.80 | 0.00 |
Otsuka Corp. | OTK | Apr 17, 2025 | 18.60 | +1.09 |
Otsuka Holdings Co.,Ltd. | OS1 | Apr 17, 2025 | 41.80 | +0.48 |
Otter Tail Corporation | OT4 | Apr 17, 2025 | 69.00 | -1.43 |
Otto Energy Ltd. | O1E | Apr 17, 2025 | 0.00 | -17.86 |
OUE Limited | OUE1 | Apr 17, 2025 | 0.60 | 0.00 |
Outbrain Inc | 852 | Apr 17, 2025 | 2.80 | -3.45 |
Outfront Media | 76C0 | Apr 17, 2025 | 12.45 | 0.00 |
Outlook Therapeutics | 41O | Apr 17, 2025 | 1.15 | -6.43 |
Outokumpu | OUTA | Apr 17, 2025 | 3.17 | +0.51 |
OUTSURANCE GROUP LTD. | RMQ0 | Apr 17, 2025 | 3.08 | -0.65 |
Ovation Science Inc Common Shares (Canada) | 0VH | Apr 17, 2025 | 0.01 | +81.25 |
Ovb Holding | O4B | Apr 17, 2025 | 22.20 | +0.91 |
Oversea-chinese Banking Corp | OCBB | Apr 17, 2025 | 21.00 | +2.94 |
Oversea-Chinese Banking Corporation Limited | OCBA | Apr 17, 2025 | 10.57 | +2.72 |
Overstock.com, Inc. | OVER | Apr 17, 2025 | 3.40 | +9.69 |
OVH Groupe | 7U7 | Apr 17, 2025 | 11.98 | +7.25 |
OVH GROUPE UNSP.ADR/1/2 | 7U70 | Apr 17, 2025 | 4.74 | +3.04 |
Ovid Therapeutics Inc. | 1OT | Apr 17, 2025 | 0.20 | -12.28 |
Ovintiv Inc. (DE) | 47Q | Apr 17, 2025 | 29.82 | +5.74 |
Ovs SPA | 0OV1 | Apr 17, 2025 | 2.99 | -2.35 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.